Diabetic nephropathy (DN) is a major complication of diabetes with a s
ignificant repercussion in health care with few epidemiological data a
vailable in Spain. The aim of this multicenter cross-sectional study w
as to establish the prevalence of renal involvement in a large group o
f patients with type 1 (insulin-dependent) diabetes and evaluate sever
al risk factors related to its development. One thousand eight hundred
twenty-two patients (921 males, mean age: 30.5 +/- 9.7 years, diabete
s duration 14.1 +/- 9.2 years) from the Endocrinology Units of Is Span
ish hospitals were included in this study. Urinary albumin excretion (
UAE), plasma creatinine, lipid profile, HbA(1c), and family history of
hypertension and nephropathy, smoking, arterial blood pressure and BM
I were evaluated. The prevalence of microalbuminuria, established neph
ropathy (patients with macroalbuminuria and those with renal failure)
and hypertension was 14.1, 8.5 and 11.3%, respectively. On logistic re
gression analysis, using the presence or absence of established nephro
pathy as variable, smoking (P = 0.0005), years of diabetes evolution (
P < 0.00005), diastolic blood pressure (P<0.00005), HbA(1c) (P<0.00005
) and triglycerides (P=0.0008) were included in the model. When analyz
ing patients with microalbuminuria vs those with normoalbuminuria the
variables included were smoking (P = 0.005), diastolic blood pressure
(P = 0.0026), years of diabetes evolution (P < 0.00005) and HbA(1c) (P
< 0.00005). The prevalence of diabetic nephropathy DN in type 1 (insu
lin-dependent) diabetes in Spain is similar to that observed in other
European countries. The association between diabetic nephropathy DN an
d hypertension, lipid disorders and metabolic control is confirmed and
smoking appears to be an additional risk factor to be considered in d
iabetic care. (C) 1997 Elsevier Science Ireland Ltd.